Biolife Solutions Stock Net Income
| BLFS Stock | USD 24.87 1.11 4.27% |
As of the 26th of January, BioLife Solutions shows the Risk Adjusted Performance of (0.04), mean deviation of 1.71, and Standard Deviation of 2.41. BioLife Solutions technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioLife Solutions variance and potential upside to decide if BioLife Solutions is priced correctly, providing market reflects its regular price of 24.87 per share. Given that BioLife Solutions has information ratio of (0.09), we suggest you to validate BioLife Solutions's prevailing market performance to make sure the company can sustain itself at a future point.
BioLife Solutions Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 11.3753 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -18.2 M | -17.3 M | |
| Net Loss | -10.2 M | -10.8 M | |
| Net Loss | -125.8 M | -119.5 M | |
| Net Loss | (0.39) | (0.41) | |
| Net Income Per E B T | 1.59 | 2.03 |
BioLife | Net Income | Build AI portfolio with BioLife Stock |
Latest BioLife Solutions' Net Income Growth Pattern
Below is the plot of the Net Income of BioLife Solutions over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in BioLife Solutions financial statement analysis. It represents the amount of money remaining after all of BioLife Solutions operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is BioLife Solutions' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (20.18 M) | 10 Years Trend |
|
Net Income |
| Timeline |
BioLife Net Income Regression Statistics
| Arithmetic Mean | (16,970,176) | |
| Coefficient Of Variation | (209.83) | |
| Mean Deviation | 20,822,122 | |
| Median | (3,217,750) | |
| Standard Deviation | 35,608,104 | |
| Sample Variance | 1267.9T | |
| Range | 143.1M | |
| R-Value | (0.43) | |
| Mean Square Error | 1106.9T | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | (3,004,586) | |
| Total Sum of Squares | 20287T |
BioLife Net Income History
Other Fundumenentals of BioLife Solutions
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
BioLife Solutions Net Income component correlations
BioLife Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for BioLife Solutions is extremely important. It helps to project a fair market value of BioLife Stock properly, considering its historical fundamentals such as Net Income. Since BioLife Solutions' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioLife Solutions' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioLife Solutions' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (0.38) | Revenue Per Share | Quarterly Revenue Growth 0.312 | Return On Assets |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioLife Solutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Solutions' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Solutions.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in BioLife Solutions on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding BioLife Solutions or generate 0.0% return on investment in BioLife Solutions over 90 days. BioLife Solutions is related to or competes with Kestra Medical, Novocure, Azenta, STAAR Surgical, Phreesia, Pulse Biosciences, and Neogen. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene ther... More
BioLife Solutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Solutions' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Solutions upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 13.74 | |||
| Value At Risk | (4.03) | |||
| Potential Upside | 4.07 |
BioLife Solutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Solutions' standard deviation. In reality, there are many statistical measures that can use BioLife Solutions historical prices to predict the future BioLife Solutions' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.10) |
BioLife Solutions January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.71 | |||
| Coefficient Of Variation | (1,674) | |||
| Standard Deviation | 2.41 | |||
| Variance | 5.79 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.10) | |||
| Maximum Drawdown | 13.74 | |||
| Value At Risk | (4.03) | |||
| Potential Upside | 4.07 | |||
| Skewness | 1.16 | |||
| Kurtosis | 3.46 |
BioLife Solutions Backtested Returns
BioLife Solutions secures Sharpe Ratio (or Efficiency) of -0.068, which signifies that the company had a -0.068 % return per unit of risk over the last 3 months. BioLife Solutions exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLife Solutions' Risk Adjusted Performance of (0.04), mean deviation of 1.71, and Standard Deviation of 2.41 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.47, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioLife Solutions will likely underperform. At this point, BioLife Solutions has a negative expected return of -0.16%. Please make sure to confirm BioLife Solutions' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if BioLife Solutions performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
BioLife Solutions has insignificant reverse predictability. Overlapping area represents the amount of predictability between BioLife Solutions time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Solutions price movement. The serial correlation of -0.14 indicates that less than 14.0% of current BioLife Solutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.33 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
BioLife Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, BioLife Solutions reported net income of (20.18 Million). This is 105.91% lower than that of the Health Care Equipment & Supplies sector and 120.26% lower than that of the Health Care industry. The net income for all United States stocks is 103.53% higher than that of the company.
BioLife Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioLife Solutions' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioLife Solutions could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics of similar companies.BioLife Solutions is currently under evaluation in net income category among its peers.
BioLife Solutions Current Valuation Drivers
We derive many important indicators used in calculating different scores of BioLife Solutions from analyzing BioLife Solutions' financial statements. These drivers represent accounts that assess BioLife Solutions' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BioLife Solutions' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 1.4B | 773.2M | 710.4M | 1.2B | 1.1B | 1.1B | |
| Enterprise Value | 1.4B | 797.4M | 716.4M | 1.1B | 1.0B | 1.1B |
BioLife Solutions ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BioLife Solutions' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BioLife Solutions' managers, analysts, and investors.Environmental | Governance | Social |
BioLife Solutions Institutional Holders
Institutional Holdings refers to the ownership stake in BioLife Solutions that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BioLife Solutions' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BioLife Solutions' value.| Shares | Geode Capital Management, Llc | 2025-06-30 | 921.1 K | Palisade Capital Management Llc | 2025-06-30 | 919.5 K | Geneva Capital Management | 2025-06-30 | 901.8 K | Royal Bank Of Canada | 2025-06-30 | 791.3 K | Ing Investment Management Llc | 2025-06-30 | 720.1 K | Cramer Rosenthal Mcglynn Llc | 2025-06-30 | 704.2 K | Bank Of America Corp | 2025-06-30 | 671.7 K | Granahan Investment Management Inc.. | 2025-06-30 | 643.2 K | Mutual Of America Capital Management Llc | 2025-06-30 | 638.4 K | Casdin Capital, Llc | 2025-06-30 | 7.7 M | Blackrock Inc | 2025-06-30 | 5.5 M |
BioLife Fundamentals
| Return On Equity | -0.0525 | ||||
| Return On Asset | -0.0073 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 1.14 B | ||||
| Shares Outstanding | 48.15 M | ||||
| Shares Owned By Insiders | 1.74 % | ||||
| Shares Owned By Institutions | 98.26 % | ||||
| Number Of Shares Shorted | 2.99 M | ||||
| Price To Earning | 173.59 X | ||||
| Price To Book | 3.39 X | ||||
| Price To Sales | 11.96 X | ||||
| Revenue | 82.25 M | ||||
| Gross Profit | 64.37 M | ||||
| EBITDA | 1.53 M | ||||
| Net Income | (20.18 M) | ||||
| Cash And Equivalents | 46.55 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 30.17 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 3.55 X | ||||
| Book Value Per Share | 7.38 X | ||||
| Cash Flow From Operations | 8.43 M | ||||
| Short Ratio | 9.57 X | ||||
| Earnings Per Share | (0.38) X | ||||
| Price To Earnings To Growth | 65.38 X | ||||
| Target Price | 32.44 | ||||
| Number Of Employees | 159 | ||||
| Beta | 1.93 | ||||
| Market Capitalization | 1.2 B | ||||
| Total Asset | 399.49 M | ||||
| Retained Earnings | (335.1 M) | ||||
| Working Capital | 116.03 M | ||||
| Current Asset | 6.97 M | ||||
| Current Liabilities | 1.73 M | ||||
| Net Asset | 399.49 M |
About BioLife Solutions Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioLife Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioLife Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioLife Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.